Vistin Pharma ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	16.42	12.79	26.2	1.44	35.75
Cash & Short-Term Investments	16.42	12.79	26.2	1.44	35.75
Cash Growth	28.33%	-51.18%	1726.06%	-95.99%	-53.60%
Accounts Receivable	89.71	44.28	47.02	66.16	40.25
Other Receivables	15.26	7.7	12.56	5.01	2.85
Receivables	104.97	51.98	59.59	71.17	43.09
Inventory	82.13	76.67	80.17	83.45	42.91
Prepaid Expenses	-	1.75	2.81	3.14	16.09
Other Current Assets	0	-	-	-	-
Total Current Assets	203.52	143.19	168.77	159.18	137.83
Property, Plant & Equipment	223.75	229.6	219.98	219.43	167.46
Long-Term Deferred Tax Assets	-	-	14.64	28.6	27.86
Other Long-Term Assets	12.15	12.16	-	-	0
Total Assets	439.43	384.95	403.4	407.21	333.15
Accounts Payable	30.24	13.05	18.92	25.91	20.81
Accrued Expenses	-	15.82	16.59	14.67	16.58
Short-Term Debt	-	-	-	45.14	-
Current Portion of Leases	0.88	-	-	1.07	0.88
Other Current Liabilities	47.87	35.1	33.96	30.78	2.78
Total Current Liabilities	78.99	63.97	69.47	117.57	41.04
Long-Term Leases	0.62	1.33	-	2.96	0.51
Pension & Post-Retirement Benefits	6.42	6.6	8.86	13.2	15.83
Long-Term Deferred Tax Liabilities	24.59	3.52	-	-	-
Other Long-Term Liabilities	-	0	2.29	-0	0
Total Liabilities	110.61	75.42	80.63	133.73	57.38
Common Stock	44.35	44.35	44.35	44.35	44.35
Additional Paid-In Capital	73.87	129.3	206.89	206.89	206.89
Retained Earnings	210.61	135.89	71.54	22.26	24.54
Shareholders' Equity	328.82	309.53	322.77	273.49	275.77
Total Liabilities & Equity	439.43	384.95	403.4	407.21	333.15
Total Debt	1.5	1.33	-	49.17	1.39
Net Cash (Debt)	14.92	11.47	26.2	-47.73	34.36
Net Cash Growth	30.09%	-56.24%	-	-	-55.40%
Net Cash Per Share	0.34	0.26	0.59	-1.08	0.77
Filing Date Shares Outstanding	44.34	44.34	44.34	44.34	44.34
Total Common Shares Outstanding	44.34	44.34	44.34	44.34	44.34
Working Capital	124.54	79.22	99.3	41.61	96.8
Book Value Per Share	7.42	6.98	7.28	6.17	6.22
Tangible Book Value	328.82	309.53	322.77	273.49	275.77
Tangible Book Value Per Share	7.42	6.98	7.28	6.17	6.22
Machinery	-	268.64	263.53	253.37	-
Construction In Progress	-	39.09	17.91	10.24	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.